Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 2
This trial compared gataparsen and docetaxel together with docetaxel alone, for non small cell lung cancer that has spread.
Recruitment start: 1 May 2010
Recruitment end: 30 June 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Denis Talbot
Eli Lilly and Company Limited
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 15 October 2019
CRUK internal database number: 6425